MELLARIL Side Effects

6924160-3 | Aspiration, Decreased Appetite, Dysphagia, Neuromyopathy, Oesophageal Obstruction, Oesophagitis, Schizophrenia, Unevaluable Event, Weight Decreased
on Aug 12, 2010 Male patient from UNITED STATES , weighting 128.0 lb, was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, decreased appetite, dysphagia, neuromyopathy, oesophageal obstruction, oesophagitis, schizophrenia, unevaluable event, weight decreased. Mellaril dosage: 50 Mg Every Day At Hs Po. During the same period patient was treated with LITHIUM CARBONATE (300 Mg Twice Per Day Po) (View Lithium Carbonate Review and Lithium Carbonate Label ).

6388437-5 | Aspiration, Bipolar Disorder, Contusion, Diabetes Mellitus, Fall, Incontinence, Mental Retardation, Rib Fracture
Patient was taking Mellaril (View Usage). Patient had the following side effects: aspiration, bipolar disorder (What is bipolar disorder?), contusion, diabetes mellitus, fall (What is fall?), incontinence, mental retardation, rib fracture on Oct 01, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 177.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), severe mental retardation and. Mellaril dosage: 50 Mg And 200 Mg 4pm Adn Bedtime Po.

6073854-3 | Amnesia, Cardiac Disorder, Confusional State, Convulsion, Crying, Delusion, Disorientation
Adverse event was reported on Feb 09, 2009 by a Female patient taking Mellaril (View Usage) (Dosage: 100mg 1 Time Po) was diagnosed with mental disorder and. Location: UNITED STATES , 16 years of age, weighting 120.0 lb, After Mellaril was administered, patient had the following side effects: amnesia, cardiac disorder, confusional state, convulsion, crying, delusion, disorientation.

5806611-0 | Apathy, Condition Aggravated, Crying, Depressed Mood, Depression, Nervousness, Sedation, Somnolence
on Jun 30, 2008 Female patient from BRAZIL , 45 years of age, weighting 123.5 lb, was diagnosed with depression (What is depression?) and was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: apathy, condition aggravated, crying, depressed mood, depression (What is depression?), nervousness, sedation, somnolence. Mellaril dosage: 1 Df, Qd.


5771437-3 | Haematospermia
on Jun 02, 2008 Male patient from BRAZIL , 33 years of age, weighting 154.3 lb, was treated with Mellaril (View Usage). Patient had the following side effects: haematospermia. Mellaril dosage: 100 Mg Daily.

5635993-8 | Agitation, Suicide Attempt
Patient was taking Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: agitation, suicide attempt on Feb 18, 2008 from BRAZIL Additional patient health information: Female patient , 39 years of age, was diagnosed with depression (What is depression?) and. Mellaril dosage: 2 Tab/day. During the same period patient was treated with CLONAZEPAM (2 Tab/day) (View Clonazepam Review and Clonazepam Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5579070-3 | Ill-defined Disorder
Adverse event was reported on Dec 28, 2007 by a Female patient taking Mellaril (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 450.0 lb, Patient experienced the following unwanted or unexpected effects: ill-defined disorder. During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ).

5485251-X | Diabetes Mellitus
on Oct 08, 2007 Male patient from BRAZIL , 44 years of age, was diagnosed with schizophrenia, stress (What is stress?) and was treated with Mellaril (View Usage). Patient had the following side effects: diabetes mellitus. Mellaril dosage: 100 Mg At Night. During the same period patient was treated with OLCADIL (2 Mg/day) (View Olcadil Review and Olcadil Label ).

5480126-4 | Aggression, Crying, Dysgeusia, Malaise, Screaming, Somnolence, Stomatitis, Suicidal Ideation, Weight Decreased
on Oct 03, 2007 Female patient from BRAZIL , 32 years of age, weighting 114.6 lb, was diagnosed with mental disorder, depression (What is depression?) and was treated with Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: aggression, crying, dysgeusia, malaise, screaming, somnolence, stomatitis, suicidal ideation, weight decreased. Mellaril dosage: 25 Mg, Bid. During the same period patient was treated with RIVOTRIL (4 Mg, Tid) (View Rivotril Review and Rivotril Label ), AMPLICTIL (View Amplictil Review and Amplictil Label ).

5420477-2 | Fall, Insomnia, Somnolence, Trance
Patient was taking Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), insomnia, somnolence, trance on Aug 15, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, was diagnosed with anxiety (What is anxiety?) and. Mellaril dosage: Unk, Unk.

5416365-8 | Depressed Level Of Consciousness, Intentional Overdose
Adverse event was reported on Aug 09, 2007 by a Male patient taking Mellaril (View Usage) (Dosage: 1750 Mg, Once/single) . Location: JAPAN , 34 years of age, Patient had the following side effects: depressed level of consciousness, intentional overdose.

5398956-6 | Parkinsonism
on Jul 24, 2007 Male patient from UNITED STATES , 75 years of age, was diagnosed with schizophrenia and was treated with Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: parkinsonism. Mellaril dosage: 100 Mg Od Po; Years Ptc. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), COGENTIN (View Cogentin Review and Cogentin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LIBRIUM (View Librium Review and Librium Label ). Patient was hospitalized.

5265854-8 | Tardive Dyskinesia
on Mar 12, 2007 Male patient from UNITED STATES , 20 years of age, weighting 170.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: tardive dyskinesia. Mellaril dosage: 2-3 Times A Day Po. During the same period patient was treated with LITHIUM 1400 TO 900 AT FINISH IN 2004 (View Lithium 1400 To 900-at Finish In 2004- Review and Lithium 1400 To 900-at Finish In 2004- Label ), THORAZINE (View Thorazine Review and Thorazine Label ), STELLAZINE (View Stellazine Review and Stellazine Label ), HALDOL (View Haldol Review and Haldol Label ), GEODON (View Geodon Review and Geodon Label ), ABILIFY (View Abilify Review and Abilify Label ).

5249288-8 | Abnormal Behaviour, Aggression, Anger, Anorexia, Anxiety, Cognitive Disorder, Condition Aggravated, Depression
Patient was taking Mellaril (View Usage). Patient had the following side effects: abnormal behaviour, aggression, anger, anorexia, anxiety (What is anxiety?), cognitive disorder, condition aggravated, depression (What is depression?) on Feb 08, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 16 years of age, was diagnosed with affective disorder and. Mellaril dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), CANNABIS (View Cannabis Review and Cannabis Label ), SERTRALINE (View Sertraline Review and Sertraline Label ).

4951773-0 | Aggression, Condition Aggravated, Mental Impairment, Nervous System Disorder
Adverse event was reported on Mar 14, 2006 by a Male patient taking Mellaril (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: BRAZIL , 14 years of age, After Mellaril was administered, patient had the following side effects: aggression, condition aggravated, mental impairment, nervous system disorder. During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ).

4949295-6 | Aggression
on Mar 14, 2006 Male patient from BRAZIL , 14 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: aggression. Mellaril dosage: . During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ).

4867749-8 | Cardiac Disorder, Electrocardiogram Qt Prolonged
on Dec 22, 2005 Female patient from UNITED STATES , weighting 350.0 lb, was diagnosed with schizophrenia, residual type and was treated with Mellaril (View Usage). Patient had the following side effects: cardiac disorder, electrocardiogram qt prolonged. Mellaril dosage: 100 Mg Qhs Po.

4825664-X | Benign Ovarian Tumour, Blood Prolactin Increased, Computerised Tomogram Abnormal, Depression, Hormone Level Abnormal, Menstruation Irregular, Musculoskeletal Stiffness, Myoclonic Epilepsy, Ovarian Cyst
Patient was taking Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: benign ovarian tumour, blood prolactin increased, computerised tomogram abnormal, depression (What is depression?), hormone level abnormal, menstruation irregular, musculoskeletal stiffness, myoclonic epilepsy, ovarian cyst (What is ovarian cyst?) on Nov 01, 2005 from BRAZIL Additional patient health information: Female patient , 33 years of age, weighting 229.3 lb, was diagnosed with angelman's syndrome and. Mellaril dosage: 125 Mg/d. During the same period patient was treated with TOFRANIL (View Tofranil Review and Tofranil Label ), BUSPAR (View Buspar Review and Buspar Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), RIVOTRIL (0.5 Mg, Qhs) (View Rivotril Review and Rivotril Label ).

4814913-X | Paralysis
Adverse event was reported on Oct 24, 2005 by a Female patient taking Mellaril (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 69 years of age, Patient experienced the following unwanted or unexpected effects: paralysis (What is paralysis?).

4803281-5 | Catatonia, Eating Disorder, Faecal Incontinence, Urinary Incontinence
on Oct 17, 2005 Female patient from UNITED KINGDOM , 80 years of age, was treated with Mellaril (View Usage). Patient had the following side effects: catatonia, eating disorder (What is eating disorder?), faecal incontinence, urinary incontinence (What is urinary incontinence?). Mellaril dosage: .

4796844-7 | Confusional State, Difficulty In Walking, Dizziness, Gait Disturbance, Hallucination, Headache, Hepatic Function Abnormal, Pain
on Oct 04, 2005 Female patient from BRAZIL , 43 years of age, weighting 121.3 lb, was diagnosed with depression (What is depression?) and was treated with Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: confusional state, difficulty in walking, dizziness (What is dizziness?), gait disturbance, hallucination, headache (What is headache?), hepatic function abnormal, pain (What is pain?). Mellaril dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), CARBOLITIUM (View Carbolitium Review and Carbolitium Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), FRONTAL (View Frontal Review and Frontal Label ), HALDOL (View Haldol Review and Haldol Label ).

4793720-0 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mm, Dehydration, Depressed Level Of Consciousness, Hypernatraemia, Pyrexia, Rash, Renal Impairment
Patient was taking Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood creatine phosphokinase mm, dehydration, depressed level of consciousness, hypernatraemia, pyrexia, rash (What is rash?), renal impairment on Sep 21, 2005 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 92.59 lb, was diagnosed with mania and. Mellaril dosage: . During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ). Patient was hospitalized.

4777259-4 | Dehydration, Depressed Level Of Consciousness, Pyrexia, Rash, Renal Impairment, Rhabdomyolysis
Adverse event was reported on Sep 21, 2005 by a Female patient taking Mellaril (View Usage) (Dosage: ) was diagnosed with mania and. Location: JAPAN , 59 years of age, weighting 92.59 lb, Patient had the following side effects: dehydration, depressed level of consciousness, pyrexia, rash (What is rash?), renal impairment, rhabdomyolysis. Patient was hospitalized.

4756050-9 | Blood Pressure Diastolic Decreased, Coma, Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Heart Rate Increased, Overdose
on May 19, 2003 Female patient from JAPAN , 35 years of age, was diagnosed with schizophrenia and was treated with Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: blood pressure diastolic decreased, coma, depressed level of consciousness, electrocardiogram qt prolonged, heart rate increased, overdose. Mellaril dosage: 200 Mg/d. During the same period patient was treated with ZYPREXA (80 Mg/d) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4749135-4 | Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Overdose, Suicide Attempt, Ventricular Fibrillation, Ventricular Tachycardia
on May 19, 2003 Female patient from JAPAN , 35 years of age, was diagnosed with schizophrenia and was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, electrocardiogram qt prolonged, overdose, suicide attempt, ventricular fibrillation, ventricular tachycardia. Mellaril dosage: 200 Mg/d. During the same period patient was treated with ZYPREXA (80 Mg/d) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4734374-9 | Creatinine Renal Clearance Decreased, Gamma-glutamyltransferase Increased
Patient was taking Mellaril (View Usage). Patient had the following side effects: creatinine renal clearance decreased, gamma-glutamyltransferase increased on Jul 26, 2005 from BRAZIL Additional patient health information: Female patient , 30 years of age, was diagnosed with sleep disorder (What is sleep disorder?) and. Mellaril dosage: 400 Mg, Qd. During the same period patient was treated with TOPAMAX (100 Mg, Bid) (View Topamax Review and Topamax Label ), ORAP (4 Mg, Bid) (View Orap Review and Orap Label ), AKINETON (2 Mg, Qd) (View Akineton Review and Akineton Label ), DALMADORM (60 Mg, Qd) (View Dalmadorm Review and Dalmadorm Label ), CLONAZEPAM (2 Mg/d) (View Clonazepam Review and Clonazepam Label ).

4691861-X | Asthenia, Depressed Level Of Consciousness, Dysstasia, Feeling Abnormal, Nausea
Adverse event was reported on Jun 14, 2005 by a Female patient taking Mellaril (View Usage) (Dosage: 25 Mgs) was diagnosed with post-traumatic stress disorder (What is post-traumatic stress disorder?) and. Location: , 43 years of age, weighting 120.0 lb, After Mellaril was administered, patient had the following side effects: asthenia, depressed level of consciousness, dysstasia, feeling abnormal, nausea (What is nausea?).

4649994-X | Confusional State, Dizziness, Headache, Somnolence
on Apr 21, 2005 Female patient from , 24 years of age, weighting 121.3 lb, was diagnosed with depression (What is depression?) and was treated with Mellaril (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, dizziness (What is dizziness?), headache (What is headache?), somnolence. Mellaril dosage: 50 Mg, Qd. During the same period patient was treated with ^TRICLAR^ CONTRACEPTIVE (1 Df, Qd) (View ^triclar^ Contraceptive Review and ^triclar^ Contraceptive Label ), DIAZEPAM (10 Df, Once/single) (View Diazepam Review and Diazepam Label ).

4649993-8 | Confusional State, Dizziness, Headache, Somnolence
on Apr 21, 2005 Female patient from , 24 years of age, weighting 121.3 lb, was diagnosed with depression (What is depression?) and was treated with Mellaril (View Usage). Patient had the following side effects: confusional state, dizziness (What is dizziness?), headache (What is headache?), somnolence. Mellaril dosage: 50 Mg, Qd. During the same period patient was treated with ^TRICLAR^ CONTRACEPTIVE (1 Df, Qd) (View ^triclar^ Contraceptive Review and ^triclar^ Contraceptive Label ), DIAZEPAM (10 Df, Once/single) (View Diazepam Review and Diazepam Label ).

4644971-7 | Confusional State, Dizziness, Headache
Patient was taking Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: confusional state, dizziness (What is dizziness?), headache (What is headache?) on Apr 21, 2005 from Additional patient health information: Female patient , 24 years of age, weighting 121.3 lb, was diagnosed with depression (What is depression?) and. Mellaril dosage: 50 Mg, Qd. During the same period patient was treated with ^TRICLAR^ CONTRACEPTIVE (1 Df, Qd) (View ^triclar^ Contraceptive Review and ^triclar^ Contraceptive Label ).

4635260-5 | Burning Sensation, Chest Pain, Chills, Dizziness, Dyspnoea, Hyperhidrosis, Hypoaesthesia, Lung Disorder, Nausea
Adverse event was reported on Dec 03, 2004 by a Female patient taking Mellaril (View Usage) (Dosage: 50 Mg, Qd) was diagnosed with depression (What is depression?) and. Location: , 42 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: burning sensation, chest pain (What is chest pain?), chills, dizziness (What is dizziness?), dyspnoea, hyperhidrosis, hypoaesthesia, lung disorder, nausea (What is nausea?). During the same period patient was treated with PAROXETINE HCL (20 Mg, Qd) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

4635253-8 | Burning Sensation, Chest Pain, Chills, Dizziness, Dyspnoea, Hyperhidrosis, Hypoaesthesia, Lung Disorder, Nausea
on Dec 03, 2004 Female patient from , 42 years of age, weighting 172.0 lb, was diagnosed with depression (What is depression?) and was treated with Mellaril (View Usage). Patient had the following side effects: burning sensation, chest pain (What is chest pain?), chills, dizziness (What is dizziness?), dyspnoea, hyperhidrosis, hypoaesthesia, lung disorder, nausea (What is nausea?). Mellaril dosage: 50 Mg, Qd. During the same period patient was treated with PAROXETINE HCL (20 Mg, Qd) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

4597542-5 | Arrhythmia, Atrioventricular Block Second Degree, Electrocardiogram Qt Prolonged, Syncope
on Feb 24, 2005 Male patient from , child 10 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Mellaril (View Usage). After Mellaril was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrioventricular block second degree, electrocardiogram qt prolonged, syncope. Mellaril dosage: 15 Mg/d.